Belite Bio to Participate in the 2025 Maxim Growth Summit
Belite Bio (NASDAQ: BLTE) announced that its executive management team will participate in the Maxim Growth Summit on October 22, 2025.
Belite is a clinical-stage company developing novel therapeutics for degenerative retinal diseases. Investors or partners seeking a one-on-one meeting are instructed to contact their Maxim representative to schedule.
Belite Bio (NASDAQ: BLTE) ha annunciato che il suo team dirigenziale parteciperà al Maxim Growth Summit il 22 ottobre 2025.
Belite è una società in fase clinica che sviluppa terapie innovative per malattie retiniche degenerative. Gli investitori o i partner interessati a un colloquio individuale sono invitati a contattare il loro rappresentante Maxim per fissarlo.
Belite Bio (NASDAQ: BLTE) anunció que su equipo directivo participará en el Maxim Growth Summit el 22 de octubre de 2025.
Belite es una empresa en etapa clínica que desarrolla terapias novedosas para enfermedades retinales degenerativas. Los inversionistas o socios que deseen una reunión individual deben ponerse en contacto con su representante de Maxim para programarla.
Belite Bio (NASDAQ: BLTE)의 경영진이 Maxim Growth Summit에 2025년 10월 22일에 참여할 예정이라고 발표했습니다.
Belite는 퇴행성 망막 질환에 대한 새로운 치료제를 개발하는 임상 단계 기업입니다. 1:1 미팅을 원하는 투자자나 파트너는 일정 조정을 위해 Maxim 담당자에게 연락해야 합니다.
Belite Bio (NASDAQ: BLTE) a annoncé que son équipe de direction exécutive participera au Maxim Growth Summit le 22 octobre 2025.
Belite est une société en phase clinique développant des thérapies nouvelles pour les maladies rétiniennes dégénératives. Les investisseurs ou partenaires souhaitant une réunion individuelle doivent contacter leur représentant Maxim pour la programmer.
Belite Bio (NASDAQ: BLTE) gab bekannt, dass das Vorstandsteam am Maxim Growth Summit am 22. Oktober 2025 teilnehmen wird.
Belite ist ein klinisch fortgeschrittenes Unternehmen, das neue Therapeutika für degenerative Netzhauterkrankungen entwickelt. Investoren oder Partner, die ein One-on-One-Meeting wünschen, sollten ihren Maxim-Vertreter kontaktieren, um einen Termin zu vereinbaren.
Belite Bio (NASDAQ: BLTE) أعلنت أن فريق الإدارة التنفيذية سيشارك في Maxim Growth Summit في 22 أكتوبر 2025.
Belite هي شركة في طور المرحلة السريرية ت ontwikkelt علاجات جديدة لأمراض الشبكية التنكسية. يجب على المستثمرين أو الشركاء الذين يرغبون في اجتماع وجهاً لوجه الاتصال بممثل Maxim الخاص بهم لترتيب الموعد.
Belite Bio (NASDAQ: BLTE) 宣布其执行管理团队将于 2025年10月22日 参加 Maxim Growth Summit。
Belite 是一家处于临床阶段的公司，致力于开发用于退行性视网膜疾病的新型治疗药物。希望进行一对一会谈的投资者或合作伙伴请联系其 Maxim 代表进行安排。
- None.
- None.
SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will be participating in the Maxim Growth Summit on October 22, 2025.
To schedule a one-on-one meeting with management, please reach out to your Maxim representative.
About Belite Bio
Belite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical need, such as STGD1 and GA in advanced dry AMD, in addition to specific metabolic diseases. Belite’s lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of bisretinoid toxins in the eye, is currently being evaluated in a Phase 3 study (DRAGON) and a Phase 2/3 study (DRAGON II) in adolescent STGD1 subjects and a Phase 3 study (PHOENIX) in subjects with GA. For more information, follow us on X, Instagram, LinkedIn, and Facebook or visit us at www.belitebio.com.
Media and Investor Relations Contact:
Jennifer Wu
ir@belitebio.com
Julie Fallon
belite@argotpartners.com
FAQ
When will Belite Bio (NASDAQ: BLTE) participate in the Maxim Growth Summit?
How can investors schedule a one-on-one meeting with Belite Bio management at the Maxim Growth Summit?
What will Belite Bio discuss at the October 22, 2025 Maxim Growth Summit?
What is Belite Bio's (BLTE) clinical focus mentioned for the Maxim Growth Summit?
Will Belite Bio provide a public webcast or investor presentation at the Maxim Growth Summit?
Who should I contact to arrange meetings with Belite Bio management at the Maxim Growth Summit?
